Niche product focus GAVIS Pharmaceuticals operates as a niche drug product distributor with a tailored portfolio and 42,000 sq ft facility in Somerset, NJ. There are 10 current US products and 24 ANDAs filed, signaling strong potential for expanding high-margin product lines with major wholesalers and group purchasing organizations.

Expansion potential With 24 ANDAs filed and pending FDA approval and plans to launch 8-10 new products in the next 12 months, there are clear opportunities for BD teams to secure early distribution partnerships and exclusive or preferred supplier arrangements to capture new product introductions.

Direct warehousing GAVIS ships its own products from a dedicated facility without relying on 3PL, enabling faster turnarounds and potentially better commercial terms for exclusive distribution, stocking commitments, and extended payment terms with major wholesalers and chain pharmacies.

Market positioning As a small team with global-scale ambitions, GAVIS presents an opportunity to target mid-market wholesalers and regional distributors seeking nimble, relationship-driven suppliers with room to grow through additional launches and regulatory approvals.

Tech-enabled outreach Their tech stack includes Google Workspace, Cloud, and web infrastructure, suggesting receptiveness to digital sales enablement, data-driven lead generation, and online marketing collaborations to accelerate product launches and broaden the distributor network.